Ennogen

About

Ennogen is a British-based pharmaceutical and medical device company founded in 2011 by CEO John Ruprai. The company focuses on revitalizing heritage brands to address under-served clinical needs. Ennogen has expanded its geographical presence and product portfolio through multiple transactions with multinational industry leaders. The company offers a diverse portfolio of over 150 Market Authorisations, including medicines, medical devices, unlicensed medicines, and over-the-counter products. Ennogen is ISO13485 accredited and acts as the legal manufacturer and distributor of medical devices. Its commercial coverage includes UK wholesale channels, private and NHS hospitals, community and retail pharmacies, and Clinical Commissioning Groups, making it a preferred choice for pharmacists and clinicians. With approximately 34 employees and an annual revenue of $6.3 million as of 2024, Ennogen aims to be a leading international healthcare company, committed to quality and empowering patient communities worldwide.